Table 4.
Author Name | City/Country | Sample Size | Prevalence | Criteria used for GDM diagnosis |
---|---|---|---|---|
Agarwal et al. (2007) | Al Ain, United Arab Emirates | 1172 | 20.6 % | WHO 1999 |
Tan et al. (2007) | Malaysia | 1600 | 11.4 % | WHO 1999 |
Bener et al. (2011) | Doha, Qatar | 1608 | 16.3 % | WHO 1999 |
Moses et al. (2011) | Australia | 1275 | 9.6 % 13.0 % | ADIPS IADPSG |
Dahanayaka et al. (2012) | Sri Lanka | 405 | 8.9 % | IADPSG |
Jenum et al. (2012) | Oslo, Norway | 823 | 13 % 31.5 % | WHO 1999 IADPSG |
Kalter-Leibovivi et al. (2012) | Israel | 3,345 | 9 % | IADPSG |
Reyes-Munoz E et al. (2012) | Mexico | 803 | 10.3 % 30.1 % | ADA 2005 IADPSG |
Kanjana et al. (2013) | Thailand | 6324 | 2.6 % | IADPSG |
Duran et al. (2014) | Madrid, Spain | 1750 1526 | 10.6 % 35.5 % | Carpenter & Coustan IADPSG |
Shang et al. (2014) | China | 3083 | 19.9 % 7.98 % | IADPSG ADA 2005 |
Liao et al. (2014) | Chengdu, China | 5630 | 11.7 % 24.5 % | ADA 2005 IADPSG |
Leng et al. (2015) | Tianjin, China | 18589 | 8.1 % 9.3 % | WHO 1999 IADPSG |
Hung et al. (2015) | Taoyuan, China | 3056 3641 | 4.6 % 12.4 % | ADA 2005 IADPSG |
Sibartie et al. (2015) | Australia | 10103 | 3.4 % 3.5 % | ADIPS IADPSG |
Ethridge et al. (2015) | Ohio, United States of America | 8390 | 4 % 3.3 % | Carpenter & Coustan IADPSG |
O’Sullivan et al. (2016) | Galway, Ireland | 5500 | 12.4 % 9.4 % | IADPSG WHO 1999 |